DOI: 10.1055/s-00035331

Revista Urología Colombiana / Colombian Urology Journal

References

Sartor AO, Morris MJ, Krause BJ.
VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of 177Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).

J Clin Oncol 2019;
37 (15_suppl): TPS5099-TPS5099 [Internet] 10.1200/JCO.2019.37.15_suppl.TPS5099

Download Bibliographical Data

Search in:
Access: